StonvexLoading…
StonvexStonvexStonvexCore line items from CBNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $15.54M | $55.84M | $40.94M | $27.51M |
Operating Income | $8.90M | $25.42M | $18.71M | $12.81M |
Net Income | $7.07M | $20.24M | $14.89M | $4.58M |
EPS (Diluted) | $1.08 | $3.08 | $2.27 | $1.55 |
Total Assets | $1.92B | $1.75B | $1.53B | $1.45B |
Total Liabilities | $1.74B | $1.58B | $1.37B | $1.29B |
Cash & Equivalents | $611.83M | $586.63M | $395.68M | $377.26M |
Free Cash Flow OCF − CapEx | $2.89M | $11.48M | $6.41M | $3.95M |
Shares Outstanding | 6.56M | 6.56M | 6.56M | 6.56M |